ARS Pharmaceuticals, Inc. Common Stock (NASDAQ: SPRY) last traded at $5.51, up 0.00% on the session. The quote above updates while this page is open; the figures below are drawn from ARS Pharmaceuticals, Inc. Common Stock’s own filings and are restated only when a new one is published.
ARS Pharmaceuticals, Inc. Common Stock trades on NASDAQ under the ticker SPRY. Its market capitalisation is $547.46 million.
Valuation measures for ARS Pharmaceuticals, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $547.46M |
|---|---|
| Enterprise value | $776.28M |
| Price / sales | 4.68 |
| Price / book | 43.75 |
| Beta | 1.54 |
Trailing-twelve-month figures tagged in ARS Pharmaceuticals, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $116.93M |
|---|---|
| Net income (TTM) | -$215.43M |
| EPS (TTM) | -$2.17 |
| Operating margin | -184.96% |
| Return on equity | -1721.80% |
| Cash | $8.16M |
Range and volume for SPRY over the past 52 weeks.
| 52-week high | $14.00 |
|---|---|
| 52-week low | $4.91 |
| Volume | 1.20M |
| Average volume | 2.04M |
| Previous close | $5.51 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.